The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AMC 095 (AIDS Malignancy Consortium): A phase I study of ipilimumab (IPI) and nivolumab (NIVO) in advanced HIV associated solid tumors (ST) with expansion cohorts in HIV associated solid tumors and classical Hodgkin lymphoma (cHL).
 
Lakshmi Rajdev
No Relationships to Disclose
 
Elizabeth Y. Chiao
No Relationships to Disclose
 
Shelly Lensing
No Relationships to Disclose
 
Richard F. Little
No Relationships to Disclose
 
Dirk Dittmer
No Relationships to Disclose
 
Mark H. Einstein
No Relationships to Disclose
 
Missak Haigentz
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - AstraZeneca
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - AstraZeneca; Celgene; Celldex; Genentech/Roche; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Prescient Therapeutics
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Prescient Therapeutics (Inst)
 
Ronald T. Mitsuyasu
Stock and Other Ownership Interests - Amgen
Research Funding - Calimmune (Inst); Sangamo Bioscience (Inst)